Wacker Chemie AG (LON:0NR4)
London · Delayed Price · Currency is GBP · Price in EUR 63.55
-5.03 (-7.33%)
At close: Aug 1, 2025
Verve Therapeutics Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 728.5 | 1,047 | 1,014 | 894.7 | 926.6 | 626 | Upgrade |
Short-Term Investments | 65.6 | 168.6 | 347.6 | 877.5 | 738.7 | 712.1 | Upgrade |
Cash & Short-Term Investments | 794.1 | 1,215 | 1,361 | 1,772 | 1,665 | 1,338 | Upgrade |
Cash Growth | -26.78% | -10.72% | -23.19% | 6.42% | 24.45% | 145.25% | Upgrade |
Accounts Receivable | 836.4 | 764.6 | 788.6 | 916.2 | 824.8 | 627 | Upgrade |
Other Receivables | 267.1 | 182.2 | 191 | 229 | 140.9 | 102.6 | Upgrade |
Receivables | 1,104 | 948.7 | 984.8 | 1,147 | 966.3 | 769.6 | Upgrade |
Inventory | 1,723 | 1,796 | 1,449 | 1,656 | 1,177 | 879.5 | Upgrade |
Prepaid Expenses | - | 30.6 | 24.5 | 11.2 | 12 | 10.4 | Upgrade |
Restricted Cash | - | 0.1 | 0.1 | 0.1 | - | - | Upgrade |
Other Current Assets | 75.5 | 65.1 | 81.8 | 73.5 | 27.4 | 31 | Upgrade |
Total Current Assets | 3,696 | 4,055 | 3,902 | 4,660 | 3,848 | 3,029 | Upgrade |
Property, Plant & Equipment | 3,446 | 3,597 | 3,261 | 2,961 | 2,606 | 2,504 | Upgrade |
Long-Term Investments | 939.1 | 1,045 | 1,037 | 1,197 | 1,040 | 611.4 | Upgrade |
Goodwill | - | 171.4 | 168.3 | 83.5 | - | - | Upgrade |
Other Intangible Assets | 264.2 | 117.2 | 125.2 | 129.5 | 45.9 | 21.1 | Upgrade |
Long-Term Deferred Tax Assets | 286 | 270.5 | 245.2 | 272.9 | 569.7 | 770.8 | Upgrade |
Other Long-Term Assets | 167.1 | 139 | 95.2 | 97.8 | 25.4 | 14.6 | Upgrade |
Total Assets | 8,798 | 9,410 | 8,854 | 9,401 | 8,134 | 6,951 | Upgrade |
Accounts Payable | 715.7 | 851.5 | 878.9 | 885.6 | 761.9 | 424.2 | Upgrade |
Accrued Expenses | - | 193.3 | 149.7 | 271.9 | 243.9 | 149.3 | Upgrade |
Current Portion of Long-Term Debt | 153.4 | 180.4 | 387.1 | 428.3 | 346.7 | 58 | Upgrade |
Current Portion of Leases | - | 40.8 | 30.4 | 33.1 | 26.1 | 24.8 | Upgrade |
Current Income Taxes Payable | 15.1 | 39.2 | 44.6 | 92.2 | 69 | 12.5 | Upgrade |
Current Unearned Revenue | 70.8 | 82.8 | 94.4 | 93.7 | 169.5 | 64.4 | Upgrade |
Other Current Liabilities | 322.9 | 134.8 | 177.9 | 122.5 | 94.8 | 93.1 | Upgrade |
Total Current Liabilities | 1,278 | 1,523 | 1,763 | 1,927 | 1,712 | 826.3 | Upgrade |
Long-Term Debt | 1,460 | 1,436 | 876.4 | 857.6 | 936.4 | 1,225 | Upgrade |
Long-Term Leases | 322.2 | 289.9 | 211.7 | 228 | 127.6 | 98 | Upgrade |
Long-Term Unearned Revenue | 202.2 | 219.1 | 224.1 | 225.6 | 56.3 | 71.1 | Upgrade |
Long-Term Deferred Tax Liabilities | 21.9 | 24.2 | 26.3 | 35.6 | 9.7 | 9.1 | Upgrade |
Other Long-Term Liabilities | 319.7 | 328.9 | 338.1 | 327.7 | 378.6 | 316.1 | Upgrade |
Total Liabilities | 4,296 | 4,573 | 4,275 | 4,371 | 5,034 | 5,259 | Upgrade |
Common Stock | 260.8 | 260.8 | 260.8 | 260.8 | 260.8 | 260.8 | Upgrade |
Additional Paid-In Capital | 157.8 | 158.5 | 158.6 | 158.9 | 157.4 | 157.4 | Upgrade |
Retained Earnings | 3,940 | 4,097 | 4,005 | 4,287 | 3,434 | 2,726 | Upgrade |
Treasury Stock | -45.1 | -45.1 | -45.1 | -45.1 | -45.1 | -45.1 | Upgrade |
Comprehensive Income & Other | 25.9 | 198.4 | 37.9 | 202.1 | -788.1 | -1,474 | Upgrade |
Total Common Equity | 4,340 | 4,669 | 4,417 | 4,864 | 3,019 | 1,625 | Upgrade |
Minority Interest | 162.8 | 167.8 | 163.1 | 166.9 | 81.9 | 66.6 | Upgrade |
Shareholders' Equity | 4,503 | 4,837 | 4,580 | 5,031 | 3,100 | 1,692 | Upgrade |
Total Liabilities & Equity | 8,798 | 9,410 | 8,854 | 9,401 | 8,134 | 6,951 | Upgrade |
Total Debt | 1,936 | 1,947 | 1,506 | 1,547 | 1,437 | 1,406 | Upgrade |
Net Cash (Debt) | -1,141 | -731.4 | -144.3 | 225.2 | 228.5 | -67.4 | Upgrade |
Net Cash Growth | - | - | - | -1.44% | - | - | Upgrade |
Net Cash Per Share | -22.98 | -14.72 | -2.90 | 4.53 | 4.60 | -1.36 | Upgrade |
Filing Date Shares Outstanding | 39.18 | 49.68 | 49.68 | 49.68 | 49.68 | 49.68 | Upgrade |
Total Common Shares Outstanding | 39.18 | 49.68 | 49.68 | 49.68 | 49.68 | 49.68 | Upgrade |
Working Capital | 2,419 | 2,533 | 2,139 | 2,733 | 2,136 | 2,202 | Upgrade |
Book Value Per Share | 110.75 | 93.99 | 88.91 | 97.91 | 60.76 | 32.71 | Upgrade |
Tangible Book Value | 4,076 | 4,381 | 4,123 | 4,651 | 2,973 | 1,604 | Upgrade |
Tangible Book Value Per Share | 104.01 | 88.18 | 83.00 | 93.62 | 59.84 | 32.29 | Upgrade |
Land | - | 2,005 | 1,821 | 1,757 | 1,669 | 1,600 | Upgrade |
Machinery | - | 10,471 | 9,760 | 9,582 | 9,246 | 8,859 | Upgrade |
Construction In Progress | - | 738.2 | 863.7 | 601.7 | 344 | 200.4 | Upgrade |
Order Backlog | - | 5,668 | 6,379 | 7,509 | 6,588 | 2,912 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.